Breaking News
Get 45% Off 0
Q1 Earnings Alert! Plan ahead with key data on upcoming stock reports - all in 1 place
See list
Close

Oncoclinicas do Brasil Servicos Medicos SA (ONCO3)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.47 -0.02    -0.36%
18/04 - Closed. Currency in BRL
Type:  Equity
Market:  Brazil
ISIN:  BRONCOACNOR6 
  • Volume: 1,163,900
  • Bid/Ask: 5.33 / 5.65
  • Day's Range: 5.21 - 5.64
Oncoclinicas do Brasil Servicos Medicos 5.47 -0.02 -0.36%

Oncoclinicas do Brasil Servicos Medicos Company Profile

 
Explore the Oncoclinicas do Brasil Servicos Medicos company profile for core details about Oncoclinicas do Brasil Servicos Medicos, assess Oncoclinicas do Brasil Servicos Medicos company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

-

Equity Type

ORD

Oncoclínicas do Brasil Serviços Médicos S.A. provides healthcare services focused on oncology, hematology, and radiotherapy in Latin America. It offers diagnosis and treatment services, such as pathological analysis, cryotherapy, palliative care, delife, hilotherapy, molecular journey, laser therapy, integrative medicine, myelogram-bone marrow biopsy, OC care line, OC precision medicine, oncoACCESS, survivorship, telemedicine, genetic testing, personalized medicine and individualized treatment, and veinviewer. The company also provides services in the areas of chemotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter salinization and heparinization, and non-oncological infusions. It has collaboration with MGI Tech Co., Ltd. to accelerates the laboratory advancements in genomic medicine. The company was founded in 2010 and is based in São Paulo, Brazil.

Contact Information

Address Avenida Presidente Juscelino Kubitschek nº 510, 2º andar
São Paulo, 04543-906
Brazil
Phone -
Fax -

Top Executives

Name Age Since Title
Marcus Vinicius Dias Severini - 2023 Fiscal Council Member
Renato Fairbanks Nascimbeni de Sá e Silva Ribeiro - 2024 Member of Fiscal Council
David Castelblanco - - Chairman
Bruno Lemos Ferrari - 2010 Vice Chairman & CEO
Flavia Maria Bittencourt 54 - Board Member
Clarissa Maria de Cerqueira Mathias - - Board Member
Marcus Vinicius Dias Severini 66 2023 President of the Fiscal Council
Eric P. Winer - 2022 Director
Allen Mc Michael Gibson - - Board Member
Marcelo del Vigna - 2022 Independent Director
Joao Carlos Figueiredo Padin - 2024 Chief Strategy Officer & Board Member
Reginaldo Ferreira Alexandre 66 2024 Member of Fiscal Council
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ONCO3 Comments

Write your thoughts about Oncoclinicas do Brasil Servicos Medicos SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email